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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThemicroenvironment is a criticalmediator of stem cell survival, proliferation,migration, and differentiation. Themajority of preclinical
studies involving transplantation of neural stem cells (NSCs) into the CNS have focused on injured or degeneratingmicroenvironments,
leaving a dearth of information as to how NSCs differentially respond to intact versus damaged CNS. Furthermore, single, terminal his-
tological endpoints predominate, providing limited insight into the spatiotemporal dynamics of NSC engraftment and migration. We
investigated the early and long-term engraftment dynamics of human CNS stem cells propagated as neurospheres (hCNS-SCns)
following transplantation into uninjured versus subacutely injured spinal cords of immunodeficient NOD-scidmice. We stereologically
quantified engraftment, survival, proliferation, migration, and differentiation at 1, 7, 14, 28, and 98 days posttransplantation, and
identified injury-dependent alterations. Notably, the injured microenvironment decreased hCNS-SCns survival, delayed and altered
the location of proliferation, influenced both total and fate-specific migration, and promoted oligodendrocyte maturation.INTRODUCTION
Spinal cord injury (SCI) affects approximately 1,275,000
people in the United States alone, at a cost of over
$40.5 billion annually (Christopher &Dana Reeve Founda-
tion, 2009). Human neural stem cell (hNSC) transplan-
tation has emerged as an approach to promote repair
or regeneration of the damaged CNS. However, the role
of the transplantation niche in hNSC survival, prolifera-
tion, migration, and differentiation has received little
attention.
A niche provides extrinsic cues that influence many
aspects of stem cell biology (Decimo et al., 2012). Accord-
ingly, a transplantation niche in an injured microen-
vironment could alter both the engraftment dynamics
and the availability of differentiation cues. At least
two paradigms can be postulated for the dynamics of
transplanted cell engraftment (Figure 1A) and migration
(Figure 1B) in the spinal cord. The injured microen-
vironment could alter these dynamics by causing a
paradigm shift or enhancing/impairing one paradigm.
Furthermore, the injured microenvironment could alter
the lineage-specific differentiation or localization of trans-
planted cells.
In previous studies, we tested the transplantation of hu-
man CNS stem cells propagated as neurospheres (hCNS-
SCns; Uchida et al., 2000) into immediate, subacute, and
chronic microenvironments following contusive SCI in620 Stem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The AuthorsNOD-scid mice (Cummings et al., 2005, 2006, 2008;
Hooshmand et al., 2009; Salazar et al., 2010), C57Bl/6
mice (Sontag et al., 2013), and athymic nude rats (Piltti
et al., 2013a, 2013b). In those studies, we identified robust
engraftment, long-term survival, proliferation, differentia-
tion, and extensive migration, along with improved
locomotor function, with no evidence of allodynia or
hyperalgesia. Although it has been suggested that cell
engraftment could be adversely affected by transplantation
timing (Okano et al., 2003), we have reported that stereo-
logical quantification of engrafted cells after immediate,
subacute, or early chronic transplantation revealed similar
total numbers of human cells 12–16 weeks posttransplan-
tation (Cummings et al., 2005, 2006, 2008; Hooshmand
et al., 2009; Salazar et al., 2010). Our objective in the
present study was to investigate the effect of the transplan-
tation niche and injured microenvironment on the spatio-
temporal dynamics of hNSC engraftment. For these
experiments, we focused on the subacute hCNS-SCns
transplantation paradigm, which was previously demon-
strated to improve locomotor function (Cummings et al.,
2005, 2008; Hooshmand et al., 2009).RESULTS
To investigate the dynamics of hCNS-SCns engraftment,
we quantified SC121, a human cytoplasmic marker, in
Figure 1. Spatiotemporal Dynamics Para-
digms
(A) Engraftment paradigm 1: minimal cell
death followed by limited (1- to 2-fold)
proliferation. Engraftment paradigm 2:
extensive cell death followed by extensive
(3- to 4-fold) proliferation.
(B) Proliferation paradigm 1: cells prolifer-
ate near the site of transplantation prior to
migrating away. Proliferation paradigm 2:
cells migrate from the site of trans-
plantation and then proliferate. Prolifera-
tion paradigm 3: cells proliferate and
migrate concomitantly. The white structure
represents the spinal cord, the purple region
represents the lesion, and the dashed line
indicates the midline. Predictions for rostral
and caudal regions were set as equivalent in
these paradigms.
See also Figure S7.
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SCI Alters hNSC Engraftment Dynamicsconjunction with bromodeoxyuridine (BrdU) or KI67,
markers for mitotically active cells, or cleaved caspase 3
(CC3), a marker for cellular apoptosis. Lineage-specific dif-
ferentiation of hCNS-SCns was determined by double-
labeling immunohistochemistry for SC121 in combination
with OLIG2 (oligodendrocytic) or DCX (neuronal), or
single labeling for SC123 (human astrocytic). Representa-
tive images of coronal sections for human cells with prolif-
erating or apoptotic cells are shown in Figures 2 and S1
(available online). Stereological quantification for these
markers was performed on all animals.StehCNS-SCns Engraftment Is Altered in the Injured
Microenvironment
All animals exhibited labeling for human cells at all time
points, demonstrating 100% engraftment success. We
investigated changes in the total hCNS-SCns number at
1, 7, 14, 28, and 98 days posttransplantation (dpt) in
injured and uninjured mice (Figure 3A). Two-way ANOVA
identified a significant interaction for both time posttrans-
plantation (p < 0.001) and injury (p < 0.001), suggesting
that hCNS-SCns engraftment was altered in the injured
microenvironment. Analysis revealed a significant decreasem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authors 621
Figure 2. hCNS-SCns Engraftment and Proliferation
hCNS-SCns survived and proliferated in both groups, as shown in
representative images of coronal sections from uninjured and
injured spinal cords immunolabeled for SC121 (brown) and BrdU
(blue) at 1, 7, 14, 28, and 98 dpt. Scale bar, 200 mm in complete
sections and 20 mm in insets.
See also Figure S1.
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SCI Alters hNSC Engraftment Dynamicsin the number of hCNS-SCns in injured mice in com-
parison with uninjured mice at all posttransplantation
times investigated (7,739 ± 1,273 versus 18,690 ± 1,634,
p < 0. 001). Relatively few human cells were detected by
SC121 1 dpt (11% of the initial hCNS-SCns transplant
dose in injured animals and 25% in uninjured animals).
At 7 dpt, hCNS-SCns numbers had not changed signifi-
cantly from 1 dpt levels in injured (5,303 ± 1,463) or unin-
jured (16,910 ± 2,898) mice, and the significant difference
in total hCNS-SCns number between injured and unin-
jured groups persisted (p < 0.01). By 14 dpt, significantly
higher hCNS-SCns numbers were observed in both injured
(16,450 ± 3,334, p < 0.01) and uninjured (35,210 ± 3,466,
p < 0.01) mice in comparison with 7 dpt. Injured mice still
retained fewer hCNS-SCns than uninjured mice (p < 0.01)
at 14 dpt. hCNS-SCns number in injured mice at 28 dpt622 Stem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authorswas not significantly different from that at 14 dpt (25,640
± 4,320); however, hCNS-SCns number in uninjured mice
had increased significantly (123,100 ± 25,450, p < 0.05).
Nonetheless, the 28 dpt hCNS-SCns number in injured
mice was again significantly increased in comparison
with both 1 and 7 dpt (p < 0.001, p < 0.001), and hCNS-
SCns in injured mice continued to be significantly lower
than in uninjured mice (p < 0.01). At 98 dpt, injured spinal
cord still had a significantly decreased number of hCNS-
SCns compared with uninjured spinal cord (214,900 ±
36,380 versus 319,700 ± 11,950, respectively; p < 0.05).
Finally, hCNS-SCns number had significantly increased in
both injured and uninjured groups in comparison with
28 dpt (p < 0.001, p < 0.001).
The differences in engraftment numbers in injured
versus uninjured spinal cord over time suggested that dif-
ferential expansion was occurring. To test this hypothesis,
we performed a comparative best-fit analysis between a
straight line (linear) and second-order polynomial
(quadratic) equation on the engraftment numbers over
time. From 1 to 28 dpt, engraftment in injured mice best
fit a straight line (linear) model (R2 = 0.9261), whereas
engraftment in uninjuredmice best fit a second-order poly-
nomial (quadratic)model (R2 = 0.9993). However, from1 to
98 dpt, both injured and uninjured mice fit a second-order
polynomial (quadratic) model (R2 = 0.9994 and R2 =
0.9848, respectively). Taken together, these data suggest
that hCNS-SCns expansion began later in the injured
microenvironment.
Although CC3 was detected in mouse cells at early
time points, CC3 was not found to be colocalized with
SC121+ hCNS-SCns at any of the assessed time points
(Figure S1). These data suggest that the human cells did
not undergo significant apoptotic cell death, even 24 hr
after injection. However, these data also suggest that a
relatively small percentage of the initially transplanted
hCNS-SCns survived after injection into the uninjured
spinal cord, and may have been further reduced by micro-
environmental factors in injured mice. Despite this obser-
vation, a steady, significant increase in total hCNS-SCns
number was observed in both groups over time. Addition-
ally, the hCNS-SCns number increased at a greater rate in
the uninjured spinal cord during the first 28 dpt, suggest-
ing increased proliferation during this time. These data
would support an engraftment paradigm similar to the
second paradigm (extensive cell loss followed by increased
proliferation) in Figure 1A. In contrast, the total number
of hCNS-SCns between 28 and 98 dpt increased 2.6-fold
in the uninjured spinal cord, compared with 8.4-fold in
the injured spinal cord. These data suggest that hCNS-
SCns either expanded at a greater rate in the injured
spinal cord or were lost in the uninjured spinal cord in
the interim.
Figure 3. Stereological Quantification of
hCNS-SCns Engraftment and Migration
(A) Total number of engrafted hCNS-SCns
1, 7, 14, 28, and 98 dpt. Statistics: two-
way ANOVA followed by Bonferroni’s multi-
ple comparison test. */**/*** denote
comparisons between groups (uninjured
versus injured) at a specific time point.
#/##/### denote comparisons between
time points within one group (uninjured or
injured). */#p < 0.05, **/##p < 0.01,
***/###p < 0.001.
(B–F) Normalized localization of hCNS-SCns
at 1 (B), 7 (C), 14 (D), 28 (E), and 98 (F)
dpt. Red line, injury epicenter; gray lines,
transplant sites. Negative distances are
rostral and positive distances are caudal
to the injury epicenter, which is defined
as zero. Statistics: two-way repeated-mea-
sures ANOVA followed by Bonferroni’s mul-
tiple comparison test. *p < 0.05, **p <
0.01, ***p < 0.001. All graphs are means ±
SEM from nR 6 animals/group.
See also Figures S2 and S7.
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SCI Alters hNSC Engraftment DynamicshCNS-SCns Migration Is Altered in the Injured Spinal
Cord in a Time-Dependent Manner
Stereological quantification of hCNS-SCns provided posi-
tional data that allowed us to assess hCNS-SCns migration
at 1, 7, 14, 28, and 98 dpt (Figures 3B–3F). Two-way
repeated-measures ANOVA revealed a significant main
effect for distance on cell number (p < 0.001) and an
interaction effect for group, suggesting that the injured
spinal cord microenvironment altered hCNS-SCns migra-
tion in a time-dependent manner. Because hNCS-SCns
engraftment was lower in the injured spinal cord at all
time points, we normalized the raw migration data (Fig-
ure S2) to the total cell number tomore accurately compare
hCNS-SCns distribution along the rostral-caudal axis (Fig-
ure 3). Analysis of the normalized distribution data demon-Stestrated that injury did not influence the distribution of
hCNS-SCns at 1, 7, 14, or 28 dpt. However, at 98 dpt, we
identified a significant difference in the distribution of
hCNS-SCns between injured and uninjured spinal cords
(p < 0.01; Figure 3F). In the injured spinal cord, there was
a shift to a greater percentage of hCNS-SCns (20%)
residing 1 mm rostral and caudal to the injury epicenter,
with lower percentages of hCNS-SCns found distal to this
region. Therefore, although the distribution of subacutely
transplanted hCNS-SCns was not modulated by injury in
the first 28 dpt, hCNS-SCns at 98 dpt were differentially
localized near the epicenter of the injured spinal cord,
suggesting that the spatiotemporal profile of proliferation
and migration of human cells was altered in the injured
spinal cord.m Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authors 623
Figure 4. Stereological Quantification of
Proliferation and Migration of Prolifer-
ating hCNS-SCns
(A) Percentage of BrdU+ hCNS-SCns at 1, 7,
14, and 28 dpt. Statistics: two-way ANOVA
followed by Bonferroni’s multiple compari-
son test. */**/*** denote comparisons
between groups (uninjured versus injured)
at a specific time point. #/##/### denote
comparisons between time points within
one group (uninjured or injured). */#p <
0.05, **/##p < 0.01, ***/###p < 0.001.
(B–F) Normalized localization of BrdU+
hCNS-SCns at 1 (B), 7 (C), 14 (D), 28 (E), and
98 (F) dpt. Data obtained at 1, 7, 14, and
28 dpt reflect a terminal BrdU pulse,
and those obtained at 98 dpt reflect
cumulative BrdU pulses. Red line, injury
epicenter; gray lines, transplant sites.
Negative distances are rostral and positive
distances are caudal to the injury epicenter,
which is defined as zero. Statistics: two-
way repeated-measures ANOVA followed by
Bonferroni’s multiple comparison test. *p <
0.05, **p < 0.01, ***p < 0.001. All graphs
are means ± SEM from nR 6 animals/group.
See also Figures S3 and S5–S7.
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SCI Alters hNSC Engraftment DynamicshCNS-SCns Proliferation Is Altered in the Injured
Spinal Cord
We investigated changes in hCNS-SCns proliferation via
terminal BrdU incorporation at 1, 7, 14, and 28 dpt in
injured and uninjured mice (Figure 4A). Two-way ANOVA
identified a significant interaction for both time (p <
0.001) and the presence of an injury (p < 0.01), suggesting
that hCNS-SCns proliferationwas altered in the injured spi-
nal cord. NG2+ glial progenitors, astrocytes, microglia, and
macrophages (McTigue et al., 2001; Zai andWrathall, 2005)
have been reported to proliferate extensively in the early
postinjury period. Our data corroborate extensive host
cell proliferation at this time point (SC121/BrdU+; Fig-
ure 2). However, virtually no hCNS-SCns were mitotically
active (SC121+/BrdU+) at 1 dpt in either injured or unin-
jured mice (0.7% ± 0.2% versus 0.4% ± 0.3%). At 7 dpt,624 Stem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authorsthe proliferation of hCNS-SCns remained unchanged in
injuredmice (1.7% ± 0.8%), but had increased significantly
in uninjured mice (6.6% ± 1.3%, p < 0.001). Consequently,
hCNS-SCns proliferation in injured mice at 7 dpt was
significantly lower than in uninjured mice (p < 0.01). At
14 dpt, hCNS-SCns proliferation had not significantly
changed in injured (2.4% ± 0.5%) or uninjured (5.3% ±
0.9%) mice in comparison with 7 dpt. However, hCNS-
SCns proliferation still remained significantly lower in
injured mice compared with uninjured mice (p < 0.05).
At 28 dpt, neither injured nor uninjured hCNS-SCns prolif-
eration had changed significantly in comparison with
14 dpt (6.8% ± 2.6% and 10.9% ± 3.8%, respectively).
However, 28 dpt, hCNS-SCns proliferation had signifi-
cantly increased in comparison with 1 dpt in injured
mice (p < 0.05). Finally, no significant difference between
Stem Cell Reports
SCI Alters hNSC Engraftment DynamicshCNS-SCns proliferation was detected between injured
and uninjured mice at 28 dpt, the longest terminal BrdU
time point assessed.
In order to evaluate whether hCNS-SCns proliferation re-
mained comparable between injured and uninjured mice
for the term of the experiment, we quantified KI67 expres-
sion at 98 dpt. KI67 is a commonly used proliferation
marker that is present during G1, S, G2, and M phases of
the cell cycle, but absent from resting G0 cells (Sawhney
and Hall, 1992; Hurelbrink et al., 2002). In parallel with
BrdU incorporation data at 28 dpt, we found no significant
difference in the percentage of hCNS-SCns expressing
nuclear KI67 in the injured or uninjured spinal cord at
98 dpt (10.9% ± 0.8% versus 11.0% ± 2.2%, respectively;
Figures S3A and S3B).
In parallel, we found no evidence of tumor formation
in any animals that received hCNS-SCns. Importantly,
although 10% of cells were immunopositive for KI67
98 dpt, KI67 expression overestimates the number of
actively dividing cells, as quiescent cells can exhibit KI67
expression at sites of RNA synthesis (Gerdes et al., 1984;
Bullwinkel et al., 2006). Furthermore, because KI67 is ex-
pressed in G1, S, G2, and M phase, it is detected in a larger
proportion of cells than specific M or S phase markers (e.g.,
phosphohistone-3 (PH3) or BrdU, respectively) (Kill, 1996;
Starborg et al., 1996; Tanaka et al., 2011). To address this
issue, we performed triple immunolabeling for SC121,
KI67, and PH3, which revealed that only a small subpopu-
lation of KI67 cells were indeed PH3+ (1%–3%; Figures
S3C–S3F). Furthermore, triple immunolabeling for SC121
and KI67 in conjunction with neural lineage markers (Fig-
ure S4) revealed that only OLIG2+ hCNS-SCns were also
KI67+. These data suggest that the level of active hCNS-
SCns proliferation at 98 dpt was minimal, significantly
lower than that identified by KI67 labeling, and restricted
to cells in a progenitor/precursor pathway, indicating line-
age commitment rather than maintenance as a multipo-
tent stem cell population.
Finally, to assess the overall effect of the injuredmicroen-
vironment on hCNS-SCns proliferation, we investigated
cumulative BrdU incorporation after weekly administra-
tion until sacrifice at 98 dpt (Figure S5). We identified a sig-
nificant decrease in BrdU incorporation in hCNS-SCns over
the 98 days of engraftment in the injured versus the unin-
jured spinal cord (16.2% ± 1.9% versus 30.9% ± 2.0%
respectively; p < 0.001). Taken together, these data suggest
that the initial reduction in hCNS-SCns proliferation
within the first 28 dpt in the injured compared with the
uninjured microenvironment created a cumulative overall
deficit in hCNS-SCns proliferative activity across the entire
survival period. Furthermore, these data support engraft-
ment paradigm 2 (extensive cell loss followed by increased
proliferation) proposed in Figure 1A.SteLocalization of hCNS-SCns Proliferation Is Altered in
the Injured Spinal Cord
We next tested proliferation and migration dynamics
(Figure 1B) by assessing the migration of proliferating
hCNS-SCns, as visualized by terminal BrdU incorporation,
at 1, 7, 14, and 28 dpt, as well as cumulative weekly BrdU
incorporation at 98 dpt (Figures 4B–4F). We again normal-
ized the raw migration data (Figure S6) to the total cell
number to compare proliferating hCNS-SCns distribution
along the rostral-caudal axis. Two-way repeated-measures
ANOVA revealed a significant main effect for distance on
cell number (p < 0.001) and an interaction effect for injury
at the time points indicated below, suggesting that the
localization of hCNS-SCns proliferation was altered in the
injured spinal cord. At 1 dpt, the small number of prolifer-
ating hCNS-SCns observed were closely localized to the
initial injection site (Figure 4B), regardless of whether the
spinal cord was injured or not. However, at 7 dpt (p <
0.01; Figure 4C), 14 dpt (p < 0.001; Figure 4D), and 28
dpt (p < 0.05; Figure 4E), the distance at which proliferating
hCNS-SCns were observed relative to the initial injection
site was significantly decreased in injured animals. By 28
dpt, proliferating hCNS-SCns were found up to 2mmdistal
to the injury epicenter in the injured spinal cord versus
4 mm in the uninjured spinal cord. Following weekly
BrdU administration, the cumulative percentage of BrdU+
hCNS-SCns at 98 dpt (Figure 4F) in the injured spinal
cord remained lower than in the uninjured spinal cord
(p < 0.001), and a smaller percentage of proliferating cells
was found to be migrating along the length of the injured
spinal cord. Taken together, these data suggest that the
dynamics of hCNS-SCns proliferation and migration
were altered by the injured microenvironment, such that
proliferation occurred near the site of transplantation and
prior to migration in the injured spinal cord (paradigm 1
in Figure 1B), as opposed to multiple waves alternating
with migration in the uninjured spinal cord (paradigm 2
in Figure 1B). These differences resulted in a cumulative
shift in the localization of human cells as illustrated in
Figure S7.
The Majority of hCNS-SCns Differentiate into the
Oligodendrocytic Lineage, Regardless of Injury
Next, to test the hypothesis that the injured microenviron-
ment would alter hCNS-SCns differentiation, we investi-
gated the percentage of hCNS-SCns that expressedmarkers
for the oligodendrocytic (OLIG2), astrocytic (SC123), and
neuronal (DCX) lineages at 98 dpt (Figure 5D). A reduced
percentage of hCNS-SCns expressing OLIG2+ was detected
in injured versus uninjured spinal cord (45.6% ± 6.0%
versus 67.5% ± 4.7%, respectively; p < 0.05). No dif-
ferences in the percentages of hCNS-SCns expressing
SC123 (9.1% ± 1.0% versus 8.9% ± 2.5%, n.s.) or DCXm Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authors 625
Figure 5. Stereological Quantification of
hCNS-SCns Differentiation and Migration
of Specific Lineages
(A–C) Representative confocal images of
spinal cords fluorescently immunolabeled
for SC121 in conjunction with GFAP (A), Dcx
(B), and OLIG2 (C). Scale bar, 20 mm.
(D) Percentage of hCNS-SCns in astrocytic,
neuronal, and oligodendrocytic lineages in
uninjured versus injured spinal cords at
98 dpt. Statistics: two-tailed Student’s
t test.
(E) Raw localization of hCNS-SCns in as-
trocytic, neuronal, and oligodendrocytic
lineages in uninjured versus injured spinal
cords at 98 dpt.
(F) Normalized localization of hCNS-SCns in
astrocytic, neuronal, and oligodendrocytic
lineages in uninjured versus injured spinal
cords at 98 dpt. Red line, injury epicenter;
gray lines, transplant sites. Negative dis-
tances are rostral and positive distances
are caudal to the injury epicenter, which
is defined as zero. Statistics: two-way
repeated-measures ANOVA followed by
Bonferroni’s multiple comparison test. *p <
0.05, **p < 0.01, ***p < 0.001. All graphs
are means ± SEM from n R 6 animals/
group.
See also Figure S4.
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SCI Alters hNSC Engraftment Dynamics(17.2% ± 2.3% versus 15.6% ± 2.6%, n.s.), were detected in
injured versus uninjured spinal cord. These data suggest
that the injured microenvironment altered oligodendrog-
lial differentiation, but the majority of hCNS-SCns still
differentiated along the oligodendrocytic lineage.
TheMigration of hCNS-SCns Differentiating along the
Oligodendrocytic and Astrocytic Lineages Is Altered in
the Injured Spinal Cord
Next, we investigated how the injured microenvironment
altered the migration and distribution of specific hCNS-
SCns fates at 98 dpt (Figure 5E). A significant decrease in
the number of OLIG2+ hCNS-SCns was found at all dis-
tances along the spinal cord of injured animals in compar-
ison with uninjured animals (p < 0.001); however, no626 Stem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authorsdifference was seen in DCX+ hCNS-SCns number or distri-
bution. A significant spike in the number of GFAP+ hCNS-
SCns was present at the lesion epicenter of injured mice
versus naive mice (p < 0.05); otherwise, there was no
difference between groups. As described above, to better
compare the distribution data, we normalized the stereo-
logical counts to the total hCNS-SCns number. Analysis
of normalized data (Figure 5F) revealed that the localization
of OLIG2+ hCNS-SCns in the injured cordwas significantly
altered by injury (p < 0.01), exhibiting localized peaks
around the injury epicenter, as opposed to an even
rostral-caudal distribution in the uninjured spinal cord.
No difference in DCX+ hCNS-SCns was observed between
groups. However, a significant increase in the percentage
of SC123+ hCNS-SCns was present in injured animals
Figure 6. 3D Reconstructions of hCNS-SCns Engraftment, Pro-
liferation, and Differentiation
3D reconstructions of hCNS-SCns engraftment, proliferation, and
differentiation into oligodendrocytic, astrocytic, and neuronal
lineages at 98 dpt in uninjured and injured spinal cords. Red arrows,
injury epicenter; blue arrows, transplant sites.
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SCI Alters hNSC Engraftment Dynamicsdirectly at the injury epicenter (p < 0.001), nearly propor-
tional to the decrease in the percentage of OLIG2+ cells.
3D reconstructions of representative animals from stereol-
ogy data sets are presented in Figure 6. These data suggest
that the injured microenvironment influenced the
localized recruitment of differentiated astrocytic lineage
hCNS-SCns at the expense of the oligodendrocytic lineage.
Oligodendrocytic Maturation of hCNS-SCns Is
Increased in the Injured Spinal Cord
Finally, we assessed the coverage of lineagemarkers (SC123,
DCX, and OLIG2) for hCNS-SCns differentiation. We
found that 71.9% of hCNS-SCns in the injured spinal
cord versus 92.0% in the uninjured spinal cord were
accounted for by these three markers (Figure 7A), which
suggested the potential for a missing population of
hCNS-SCns in the injured spinal cord. Based on the differ-
ential OLIG2+ hCNS-SCns localization in the injured
spinal cord (Figures 5E and 5F), we hypothesized that a
population of hCNS-SCns in the oligodendrocytic lineage
could have eluded detection by OLIG2 quantification
alone. Nuclear OLIG2 expression is predominantly ex-
pressed in precursors/progenitors (Nishiyama et al., 2009;
Emery, 2010b), suggesting that a more mature population
of oligodendrocytes of hCNS-SCns origin could be missedSteby OLIG2 quantification. Hence, we quantified the per-
centage of hCNS-SCns expressing APC-CC1 (Figure 7B), a
more mature oligodendrocyte marker, at 98 dpt. We found
a significant difference between oligodendrocytic matura-
tion in the injured and uninjured spinal cords, with
25.5% APC/CC1+ hCNS-SCns detected in the injured spi-
nal cord versus 0.7% APC/CC1+ hCNS-SCns detected in
the uninjured spinal cord (p < 0.001; Figure 7C). When
we added APC/CC1 percentages into our lineage marker
sums (Figure 7D), the percentage of cells accounted for
increased from 71.9% to 97.4%. These data suggest that,
on the whole, the injured microenvironment shifted
hCNS-SCns in the oligodendrocytic lineage to a more
mature, APC/CC1+ phenotype.DISCUSSION
In this study, we systematically assessed the detailed
kinetics of NSC survival, migration, proliferation, and dif-
ferentiation in the injured versus uninjured microenviron-
ment, an issue that has received little attention in previous
studies despite rapid advances in stem cell transplantation
research. We report that the injured microenvironment (1)
reduced initial cell survival, but was permissive for expan-
sion of total engraftment to 2–3 times the initial cell
dose; (2) delayed early cell proliferation, which resulted
in a cumulative reduction in proliferative activity; (3)
shifted proliferation to occur closer to the lesion in the
injured spinal cord, as opposed to along the length of the
uninjured spinal cord; (4) limited the rostral/caudal migra-
tion of cells; (5) increased differentiation into more mature
oligodendrocytes; and (6) increased the proportion of
astrocytes and oligodendrocytes proximal to the injury
epicenter.
In the SCI field, subacute NSC transplantation time
points (7–10 dpi) have been postulated to increase survival
by avoiding acute inflammation (Okano et al., 2003) and
have persisted as a paradigm for the majority of preclinical
studies (Tetzlaff et al., 2011). The data presented here
demonstrate that although the injured microenvironment
at subacute time points may play a role in survival, the
majority of subacutely transplanted cells did not survive
at 1 dpt, even in an uninjured spinal cord. Recent studies
have identified a prominent role for biomechanical disrup-
tion during the injection process in determining early sur-
vival of injected cells (Aguado et al., 2012). Taken together,
these data suggest that early survival of transplanted NSC
populations may be more dependent on transplantation
parameters than on postinjury transplantation timing.
However, differences in the injured microenvironment
at different postinjury time points may still regulate the
engraftment dynamics.m Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authors 627
Figure 7. Summation of Stereologically
Quantified hCNS-SCns Lineage Analysis
and Quantification of Oligodendrocytic
Maturation
(A) Summation of stereologically quantified
hCNS-SCns in astrocytic (SC123, red), neu-
ronal (DCX, green), and oligodendrocytic
(OLIG2, blue) lineages at 98 dpt.
(B) Representative confocal immunofluo-
rescent image for SC121 (red) in conjunc-
tion with APC-CC1 (green). Scale bar, 20 mm.
(C) Quantification of oligodendrocytic
maturation of hCNS-SCns (APC+/SC121+) at
98 dpt. Statistics: two-tailed Student’s
t test. ***p < 0.001.
(D) Summation of stereologically quantified
hCNS-SCns in astrocytic (SC123, red), neu-
ronal (DCX, green), early oligodendrocytic
(OLIG2, blue), and late oligodendrocytic
(APC-CC1, gray) lineages at 98 dpt. All
graphs are means ± SEM from n = 3 animals/
group.
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SCns increased dramatically in both the injured and unin-
jured spinal cords (15-fold and 20-fold, respectively) when
calculated relative to the number of surviving cells and not
transplantation dose. Despite this observation, hCNS-SCns
proliferation in the injured spinal cord was delayed for the
first 28 dpt, an effect that may be influenced by multiple
factors. For example, inflammation, including toll-like
receptor (TLR) activation, can inhibit NSC proliferation
(Das and Basu, 2008; Ekdahl et al., 2009; Okun et al.,
2010; Taylor et al., 2010) and is altered in a spatiotemporal
manner after SCI (Anderson, 2002; Popovich and Jones,
2003; Anderson et al., 2004; Fleming et al., 2006; Kigerl
et al., 2007; Kigerl and Popovich, 2009; Beck et al., 2010).
Similarly, chondroitin sulfate proteoglycans (CSPGs) in
the injured spinal cord have been shown to diminish the
proliferation of both transplanted (Karimi-Abdolrezaee
et al., 2010) and endogenous (Karimi-Abdolrezaee et al.,
2012; Karus et al., 2012) NSCs.
Between 28 dpt and 98 dpt, hCNS-SCns number in-
creased 8-fold in the injured spinal cord, compared with
2-fold in the uninjured spinal cord. Again, these data
could be the result of multiple nonmutually exclusive
mechanisms. First, although hCNS-SCns proliferation
was equivalent at both 28 dpt and 98 dpt, proliferation
may have been differentially regulated in the interim
period, which would not have been detected in the
cumulative BrdU incorporation paradigm employed in
the 98 dpt cohort. Alternatively, there could have been628 Stem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authorsdecreased long-term survival of hCNS-SCns in the unin-
jured spinal cord during this period. Many newborn cells
in the dentate gyrus and subventricular zone die within
4 weeks after birth, presumably as a result of failing to
functionally integrate into circuitry (Zhao et al., 2008).
Thus, it is possible that hCNS-SCns in the uninjured spinal
cord, which in contrast to the injured spinal cord may
lack appropriate sites for integration, were pruned in the
period between 28 dpt and 98 dpt. Future studies utilizing
intermediate time points or advances in noninvasive cell-
tracking methods (Li et al., 2010) could elucidate these
mechanisms.
Despite robust proliferation, there was no evidence of
tumor formation in any animal that received hCNS-SCns.
At 98 dpt, we identified that 10% of hCNS-SCns ex-
pressed KI67, which is slightly higher than values reported
in previous studies using similar transplantation paradigms
(1%–5%) (Yan et al., 2007; Ogawa et al., 2009; Nori et al.,
2011). However, those studies did not utilize stereological
sampling methods, which preclude direct comparisons
with the work presented here. Furthermore, the majority
of transplanted cells in those studies exhibited neuronal
lineage differentiation. In contrast, we found that the
majority of hCNS-SCns differentiated along the oligoden-
droglial lineage, and that human cells expressing KI67+
also exhibited labeling for OLIG2, supporting the lineage
commitment of this cell population by 98 dpt. Oligoden-
drocyte precursor cells proliferate extensively in both
intact and injured spinal cords (Barnabe´-Heider et al.,
Stem Cell Reports
SCI Alters hNSC Engraftment Dynamics2010; Payne et al., 2013), which may suggest that trans-
planted hCNS-SCns respond to similar cues.
hCNS-SCns migration was extensive, detected by 1 week
following transplantation, and altered by the injured
microenvironment. Injury induced transplanted hCNS-
SCns to remain closer to the SCI epicenter, which has
been reported in other cases of CNS trauma and degenera-
tion (Connor et al., 2011; Leong and Turnley, 2011). As in
the case of cell survival, inflammatory chemokines and
cytokines can regulate NSC migration (Connor et al.,
2011). Alternatively, CSPGs could also play a role in
hCNS-SCnsmigration/localization (Kearns et al., 2003; Ike-
gami et al., 2005; Karimi-Abdolrezaee et al., 2010, 2012).
Surprisingly, we found that hCNS-SCns migrated in an
evenly distributed manner over even longer distances in
the uninjured compared with the injured microenviron-
ment. NSC migration in adult, intact CNS is typically in-
hibited by regulators (e.g., netrin-1) outside of specialized
sites (e.g., the rostral migratory stream) (Petit et al., 2007).
Taken together, these data suggest the potential for
transplanted hCNS-SCns to overcomemigratory repulsion,
allowing for greater surveillance of the transplantation
niche. Molecular dissection of these interactions could
permit manipulation of the injured spinal cord or trans-
planted NSCs to allow for even greater migration and
repair.
Our data demonstrate that proliferation and migration
occurred in waves from the site of transplantation in the
uninjured spinal cord (Figure 1B, paradigm 2), as opposed
to predominantly near the lesion epicenter in the injured
spinal cord (Figure 1B, paradigm 1). This suggests that
injury shifted the dynamics of hCNS-SCns migration and
proliferation from one paradigm to another. Many factors,
including FGF, Wnts, BMPs, and Shh, are altered following
SCI and could mediate this effect, given their established
roles in NSC proliferation in the CNS (Ulloa and Briscoe,
2007; Sabo et al., 2009; Ferna´ndez-Martos et al., 2011).
We also found that SCI altered the localization of specific
hCNS-SCns fates along the axis of the spinal cord.
hCNS-SCns retained amore immature, OLIG2+ phenotype
in the uninjured spinal cord and migrated in a long
and even distribution (Figure 6), whereas this population
was found predominantly in the region 1–2 mm from
the lesion epicenter in the injured spinal cord. This sug-
gests that hCNS-SCns in the injured spinal cord were
recruited to perilesional sites based on region- and niche-
specific cues.
Finally, our OLIG2 and APC/CC1 data demonstrated that
hCNS-SCns acquired a more mature oligodendrocyte
phenotype in injured spinal cord by 98 dpt. These data sug-
gest that transplanted hCNS-SCns responded not only to
localization cues but also to maturation cues specific to
the injured spinal cord. Although themechanisms of oligo-Stedendrocyte maturation remain incompletely understood,
multiple regulators, such as axonally expressed ligands,
secreted molecules, and neuronal activity, have been iden-
tified (Emery, 2010a) and all may be present in the injured
spinal cord microenvironment. The uninjured spinal
cord may lack these signals, presenting a fundamentally
different niche resulting in restricted maturation. In sum-
mary, these findings could have profound significance for
the field of regenerative medicine, as they suggest the
capacity of multipotent cells to respond dynamically to
the microenvironment in a niche-specific manner.EXPERIMENTAL PROCEDURES
Ethics Statement
All animal housing conditions, surgical procedures, and postoper-
ative care were in accordance with the guidelines of the Institu-
tional Animal Care and Use Committee of the University of
California, Irvine.hNSC Isolation and Culture
The derivation, culture, and characterization of hCNS-SCns were
described previously (Uchida et al., 2000), and the methods and
lines used in this study are identical to those described in previous
publications (Cummings et al., 2005; Hooshmand et al., 2009; Sal-
azar et al., 2010; Piltti et al., 2013a, 2013b). Briefly, hCNS-SCns
were propagated as neurospheres in supplemented X-Vivo 15
media (Lonza). On the day of transplantation, cells at passage 9
were dissociated into single cells and triturated to a volume of
75,000 cells/ml in X-Vivo 15 media for transplantation.Contusion Injuries, Cell Transplantation, and
Behavior
For early hCNS-SCns engraftment-dynamics experiments, contu-
sion SCIs followed by subacute hCNS-SCns transplantation into
the intact parenchyma were performed as described previously
(Cummings et al., 2005; Hooshmand et al., 2009). Briefly, adult
female NOD-scidmice (Jackson) were anesthetizedwith isoflurane,
received a T9 laminectomy using a surgical microscope, and either
a 50 kD contusion injury using the Infinite Horizon Impactor (Pre-
cision Systems and Instrumentation) (n = 40), or no injury (n = 40).
Animals were assessed behaviorally and histologically to ensure a
lack of injury in the uninjured group. Eight animals were excluded
prior to transplantation due to death or spinal cord bruising during
laminectomy procedures, one animal was excluded prior to trans-
plantation due to a contusion injury greater than 50 kD, two
animals were excluded due to injury during relaminectomy/
transplantation, and one animal was excluded mid-study due to
the development of kyphosis. Animals were selected for exclusion
by staff blinded to treatment groups in an unbiased manner based
on exclusion criteria established pre-hoc for all experiments.
Nine days after SCI/laminectomy, the mice were reanesthetized
and 250 nl of freshly triturated hCNS-SCns were injected at four
sites, two rostral and two caudal to the site of injury (for a total
of 1 ml), via a Nanoinjector (WPI Instruments) using pulled glassm Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authors 629
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SCI Alters hNSC Engraftment Dynamicspipettes with a 70 mm ID and 110 mm OD (Sutter Instruments). A
total of 75,000 cells were transplanted. Mice were randomized
into the following groups for sacrifice: 1 dpt (inj. = 8, uninj. = 8),
7 dpt (inj. n = 9, uninj. n = 8), 14 dpt (inj. n = 8, uninj. n = 10),
and 28 dpt (inj. n = 7, uninj. n = 10). 50 mg/kg BrdU in 0.9%
NaCl solution was administered intraperitoneally to all animals
20 hr and 6 hr prior to sacrifice.
For long-term hCNS-SCns engraftment experiments at 98 dpt,
the above injury and transplantation paradigm was used (inj.
n = 10, uninj. n = 10). 3 animals were excluded prior to transplan-
tation due to death or spinal cord bruising during laminectomy
procedures, 1 animal was excluded prior to transplantation due
to a contusion injury greater than 50 kD, and 1 animal was
excluded due to injury during re-laminectomy/transplantation.
Animals were selected for exclusion by staff blinded to treat-
ment groups as above. The final group numbers were inj. = 7 and
uninj. = 8. 50mg/kg BrdU in 0.9%NaCl solutionwas administered
intraperitoneally to all animals 2 dpt and then weekly thereafter
until sacrifice, 98 dpt.
Histology
Animals were anesthetized and transcardially perfused 1, 7, 14, 28,
and 98 dpt with 4% paraformaldehyde. A T6-T12 segment of the
spinal cord was dissected based on dorsal spine root counts and
postfixed in 20% sucrose/4% paraformaldehyde overnight. Tissue
was frozen in isopentane at 65C and sectioned at 30 mm coro-
nally in a cryostat using a CryoJane tape transfer system. Tissue
was processed for antigen retrieval using Buffer A (pH = 6) in the
EMS Retriever 2100 system.
Immunostaining was performed using an anti-mouse human-
specific cytoplasmic marker, SC121 (StemCells, 1:1,000), anti-
mouse human-specific astrocytic marker SC123 (StemCells,
1:1,000), anti-goat DCX (Santa Cruz, 1:100), anti-rat BrdU (Ab
Serotec, 1:250), anti-goat OLIG2 (Abcam, 1:500), anti-goat APC-
CC1 (Abcam, 1:500), anti-rabbit KI67 (Novacastra, 1:500), and
anti-rabbit cleaved caspase-3 (Cell Signaling, 1:5,000). Biotin-con-
jugated secondary antibodies were used at a dilution of 1:500 (Jack-
son) and labeling was visualized using an ABC Kit in conjunction
with DAB and SG Vector Blue (Vector Labs). DAB was used for all
human-specific labeling and SG Vector Blue was used for fate and
proliferative markers. For single-labeled sections, hematoxylin
was utilized in conjunctionwithDAB for proper cell identification.
Immunofluorescent stainingwas performed as abovewithAlexa-
Fluor 488, 555, and 647 conjugated secondary antibodies at a dilu-
tion of 1:500 in conjunction with DAPI (Invitrogen, 1:1,000).
Stereological Quantification
All quantification was performed using the optical fractionator
probe in StereoInvestigator (Microbrightfield) by individuals
blinded to the groups on an Olympus IX51 microscope with a
603 1.4NA oil objective. Six animals per group were counted
for each marker using parameters empirically determined to
achieve low coefficients of error (CE) (Table S1).
Nonlinear Regression—Curve Fit—Analysis
Mean engraftment numbers determined by stereological quantifi-
cation at 1, 7, 14, 28, and 98 dpt were subjected to a nonlinear630 Stem Cell Reports j Vol. 2 j 620–632 j May 6, 2014 j ª2014 The Authorsregression (curve fit) analysis in Prism (v 5.0a). Each data set was
compared with a straight line (linear) or second order polynomial
(quadratic) using an extra sum of F-squares test set at a threshold of
p = 0.05 to determine the best fit. R2 vales for the best-fit model
were reported.
Migration Calculations
Stereological quantification data were used to determinemigration
distances. The number of markers counted at a given section dis-
tance was expressed as a percentage of the total numbers of
markers counted. This allowed for an estimate of the percentage
of a given marker at set sampling distances throughout the region
of spinal cord analyzed (T6–T12). The same six animals used for
stereological quantification were used for migration calculations.
Statistical Analyses
Allmeans are expressed ± SEM. For in vivo stereological quantifica-
tion, a one-way ANOVA was used with Dunnett post hoc analysis.
For in vivo migrational analyses, two-way repeated-measures
ANOVAwith Bonferroni post hoc analysis was used. Prism (version
5.0a) was used for statistical analysis; significance was defined as
p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and one table
and can be found with this article online at http://dx.doi.org/10.
1016/j.stemcr.2014.03.005.
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